Leah M. Mayo

Linkoeping, E, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 61 publications

Exploring Access to Psychedelics Among Canadian Veterans: Pathways, Barriers, and Perceptions.

Exploring Access to Psychedelics Among Canadian Veterans: Pathways, Barriers, and Perceptions.

Journal: Psychedelic medicine (New Rochelle, N.Y.)

Published: August 01, 2026

EBPS2023 special issue: Stress, trauma and cannabinoids.

EBPS2023 special issue: Stress, trauma and cannabinoids.

Journal: Psychopharmacology

Published: December 17, 2025

The role of proinflammatory response and the kynurenine pathway in the association between childhood maltreatment and lifetime substance use disorder.

The role of proinflammatory response and the kynurenine pathway in the association between childhood maltreatment and lifetime substance use disorder.

Journal: Neurobiology of stress

Published: November 11, 2025

Individual and additive effects of childhood maltreatment and substance use disorder histories on baseline and stress-induced changes in peripheral stress biomarkers.

Individual and additive effects of childhood maltreatment and substance use disorder histories on baseline and stress-induced changes in peripheral stress biomarkers.

Journal: Psychopharmacology

Published: August 12, 2025

A scoping review of mystical-type experiences and mood symptom outcomes in psychedelic therapy clinical trials: comparing life-threatening disease and depressive populations.

A scoping review of mystical-type experiences and mood symptom outcomes in psychedelic therapy clinical trials: comparing life-threatening disease and depressive populations.

Journal: Therapeutic advances in psychopharmacology

Published: June 20, 2025

Functional neuroimaging of fatty acid amide hydrolase inhibition in posttraumatic stress disorder: a randomized clinical trial.

Functional neuroimaging of fatty acid amide hydrolase inhibition in posttraumatic stress disorder: a randomized clinical trial.

Journal: Translational psychiatry

Published: June 03, 2025

Examining the potential of psilocybin and 5-MeO-DMT as therapeutics for traumatic brain injury.

Examining the potential of psilocybin and 5-MeO-DMT as therapeutics for traumatic brain injury.

Journal: Progress in neuro-psychopharmacology & biological psychiatry

Published: May 02, 2025

GLP-1 receptor agonists for the treatment of alcohol use disorder.

GLP-1 receptor agonists for the treatment of alcohol use disorder.

Journal: The Journal of clinical investigation

Published: May 01, 2025

Therapeutic Effects of Low-Dose Psilocybin in Depression and Other Mental Disorders: A Systematic Review.

Therapeutic Effects of Low-Dose Psilocybin in Depression and Other Mental Disorders: A Systematic Review.

Journal: Psychedelic medicine (New Rochelle, N.Y.)

Published: April 28, 2025

Research Review: What we have learned about the endocannabinoid system in developmental psychopathology.

Research Review: What we have learned about the endocannabinoid system in developmental psychopathology.

Journal: Journal of child psychology and psychiatry, and allied disciplines

Published: April 24, 2025

Efficacy, all-cause discontinuation, and safety of serotonergic psychedelics and MDMA to treat mental disorders: A living systematic review with meta-analysis.

Efficacy, all-cause discontinuation, and safety of serotonergic psychedelics and MDMA to treat mental disorders: A living systematic review with meta-analysis.

Journal: European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology

Published: April 17, 2025

Effects of acute alcohol administration on endocannabinoids and relation to subjective effects.

Effects of acute alcohol administration on endocannabinoids and relation to subjective effects.

Journal: Psychopharmacology

Published: April 15, 2025

Showing 1-12 of 61

Last Updated: 09/26/2026